These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15554239)

  • 1. Pharmacogenetics-based new therapeutic concepts.
    Roots I; Gerloff T; Meisel C; Kirchheiner J; Goldammer M; Kaiser R; Laschinski G; Brockmöller J; Cascorbi I; Kleeberg U; Hildebrandt AG
    Drug Metab Rev; 2004 Oct; 36(3-4):617-38. PubMed ID: 15554239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype and phenotype relationship in drug metabolism.
    Roots I; Laschinski G; Arjomand-Nahad F; Kirchheiner J; Schwarz D; Brockmöller J; Cascorbi I; Gerloff T
    Ernst Schering Res Found Workshop; 2007; (59):81-100. PubMed ID: 17117716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic implications of polymorphisms in cytochromes and drug transporters].
    Münster E; Ziegler S; Brunner M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):54-8. PubMed ID: 15791777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.
    Meisel C; Roots I; Cascorbi I; Brinkmann U; Brockmöller J
    Clin Chem Lab Med; 2000 Sep; 38(9):869-76. PubMed ID: 11097342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.
    Karaca RO; Kalkisim S; Altinbas A; Kilincalp S; Yuksel I; Goktas MT; Yasar U; Bozkurt A; Babaoglu MO
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):199-206. PubMed ID: 27611887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoepigenetics: its role in interindividual differences in drug response.
    Gomez A; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2009 Apr; 85(4):426-30. PubMed ID: 19242404
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Implications of pharmacogenetics in every-day practice].
    Gerloff T; Roots I
    Internist (Berl); 2005 Nov; 46(11):1270-7. PubMed ID: 16170512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric therapeutics-how pharmacogenetics may inform drug therapy for pregnant women in the future.
    Haas DM
    Obstet Gynecol Surv; 2013 Sep; 68(9):650-4. PubMed ID: 25102121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.
    Bedada W; de Andrés F; Engidawork E; Hussein J; LLerena A; Aklillu E
    Sci Rep; 2018 Aug; 8(1):12726. PubMed ID: 30143732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics: the therapeutic drug monitoring of the future?
    Ensom MH; Chang TK; Patel P
    Clin Pharmacokinet; 2001; 40(11):783-802. PubMed ID: 11735602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of the proton pump inhibitors: a systematic review.
    Chong E; Ensom MH
    Pharmacotherapy; 2003 Apr; 23(4):460-71. PubMed ID: 12680476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.